Real-time enrollment status for this lewy body dementia psychosis clinical trial
Current Status
Recruiting
Checked: September 29, 2026 at 8:06 PM UTC
| NCT Number | NCT07095465 |
| Recruiting Status | Recruiting |
| Condition | Lewy Body Dementia Psychosis |
| Phase | PHASE3 |
| Target Enrollment | 126 participants |
| Active Locations | 18 sites in the US |
| Sponsor | ACADIA Pharmaceuticals Inc. |
| Last Updated on CT.gov | September 29, 2026 (20 hours ago) |
As of September 29, 2026: Clinical trial NCT07095465 is currently recruiting participants. This phase3 study for lewy body dementia psychosis is actively seeking new participants at 18 locations across the United States. The study is sponsored by ACADIA Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07095465 is actively recruiting participants as of September 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07095465 was last updated 20 hours ago (September 29, 2026). HelloStudys verifies this status automatically.